|Domain:||Supplier & Engineering, Mechanical Engineering / Micro Engineering|
2555 Brügg / BE
P: 032 374 30 30
F: 032 374 30 31
Find an actor
Bilan - Les Métiers de DemainLe magazine référence nous informe des nouvelles formations et de leur impact sur l'avenir des métiers de la santé...
Tolerys SATherapeutics & Diagnostics, Other
Tolerys SA is an early stage biotech company developing a novel anti-inflammatory immunotherapy named EFD BCG. This product is derived from BCG vaccine using a patented inactivation process.
Therapeutics & Diagnostics, Vaccines
Preclinical studies proved that EFD BCG relies on its unique capacity to induce regulatory T cells in several models of chronic inflammatory diseases and is associated with a favorable safety profile.
In parallel to preclinical R&D, Tolerys SA has developed EFD BCG's manufacturing process and is preparing a first-in-man clinical trial.